Multimodality treatment strategies have changed prognosis of peritoneal metastases

Figure 4 Kaplan-Meier survival curve comparing hyperthermic intraperitoneal chemotherapy to standard treatment, for colorectal peritoneal carcinomatosis[35] (with permission) (A) and comparing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy treatment to systemic chemotherapy alone, for colorectal peritoneal carcinomatosis[45] (with permission) (B). A: Kaplan-Meier survival curve comparing HIPEC to standard treatment, for Colorectal PM[35]: Available from: URL: http://click.info.copyright.com/?qs=2b7046b10dd0c5471bbbb8bac0096e00e895f442c0326423c4ec2ccdd7b4701b99fd4bd5b32f0283; B: Kaplan-Meier survival curves comparing CRS-HIPEC treatment to systemic chemotherapy alone, for Colorectal PM[45]: Available from: URL: http://click.info.copyright.com/?qs=2b7046b10dd0c5471bbbb8bac0096e00e895f442c03264235cab52a23497a2d7e22ca0949c16bf1f. CRS-HIPEC: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy; PM: Peritoneal metastases.